Zevra Therapeutics (ZVRA) FCF Margin Growth (1y) (2020 - 2026)
Zevra Therapeutics (ZVRA) FCF Margin Growth (1y) (2020 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | FCF Margin Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 1,187.00 |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 1,525.00 |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | -341.00 |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | - |
| 10 | Zevra Therapeutics | 239.71 Mn | 39.10 Mn | 34.32 Mn | 5,765.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 5,765.00 |
| Dec 31, 2025 | 15,151.00 |
| Sep 30, 2025 | 50,690.00 |
| Jun 30, 2025 | 41,956.00 |
| Mar 31, 2025 | 43,118.00 |
| Dec 31, 2024 | -966.00 |
| Sep 30, 2024 | -32,516.00 |
| Jun 30, 2024 | -33,126.00 |
| Mar 31, 2024 | -34,370.00 |
| Dec 31, 2023 | 7,305.00 |
| Sep 30, 2023 | 7,505.00 |
| Jun 30, 2023 | 106,478.00 |
| Dec 31, 2022 | -16,516.00 |
| Sep 30, 2022 | -9,872.00 |
| Jun 30, 2022 | -130,618.00 |
| Dec 31, 2021 | 1,236.00 |
| Sep 30, 2021 | -8,754.00 |
| Jun 30, 2021 | 10,667.00 |
| Mar 31, 2021 | 7,561.00 |
| Dec 31, 2020 | 17,965.00 |